# Clinical Performance of the Globe® Mapping and Ablation System for the Treatment of Atrial Fibrillation

> **NCT04954911** · — · COMPLETED · sponsor: **Kardium Inc.** · enrollment: 6 (actual)

## Conditions studied

- Atrial Fibrillation

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04954911
- **Lead sponsor:** Kardium Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-11-02
- **Primary completion:** 2023-05-23
- **Final completion:** 2023-05-23
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2023-09-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04954911

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04954911, "Clinical Performance of the Globe® Mapping and Ablation System for the Treatment of Atrial Fibrillation". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT04954911. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*